TAZVERIK ® is a registered trademark of Epizyme Inc., an Ipsen company.

GENFIT completes a royalty financing of up to €185 million with HCRx after unanimous OCEANE bondholder approval, triggering a €130 million upfront payment with potential for an additional €55 million ...

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky ...

Transaction follows Investment Grade ratings assignment from both S&P and Moody's PARIS, FRANCE, 19 March 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, ...

This office plays a key role as a strategic liaison point, capable of conducting in-depth market research and developing new ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Emotional intelligence (EI) refers to a person’s ability to recognize and understand their own and others’ emotions and to manage their emotions to achieve specific goals. Whilst not always ...

It goes without saying that modern medicine would look very different if it hadn’t been for these 15 medical inventions and discoveries of the 1800s.

She will serve on Ipsen's Executive Leadership Team (ELT ... 20 years of global leadership experience in pharmaceuticals and medical aesthetics, with a strong track record in business ...

Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment of Olivia Brown as, EVP, Global Head of Neurotoxins, effective April 1st, 2025. She will ...

PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment of Olivia Brown as, EVP, Global Head of Neurotoxins ...